GSK launches shingles vaccine, Shingrix in India
Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses for the prevention of shingles…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlaxoSmithKline Pharmaceuticals
GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores
The transaction is expected to be completed by September 30, 2021
A Vaidheesh re-elected President of OPPI
A Vaidheesh, who hold the position of Vice President, South Asia & Managing Director at GlaxoSmithKline Pharmaceuticals has…
OPPI organises conference on future of supply chain management in Mumbai
Key stakeholders of the pharma industry congregated at the event to confer and converse on the blueprint to build an effective and…
GSK and Regional Centre for Biotechnology to develop PhD programs in biostatistics and…
The programme cover scholarship and expert guidance for completion of doctoral degrees
programs to equip students with high-end…
GlaxoSmithKline Pharmaceuticals completes transaction with Novartis
Acquires the vaccines business of Novartis, divests its oncology business to Novartis GlaxoSmithKline Pharmaceuticals has…
GSK begins work on new factory to make tablets and capsules
The company commenced work on its new manufacturing facility at Vemgal in Kolar district in Karnataka UK-based GlaxoSmithKline…
GSK Pharma to invest Rs 1,000 crore at its Bengaluru facility
The facility will be operational by 2017 GlaxoSmithKline Pharmaceuticals' (GSK India) greenfield manufacturing facility at…
GlaxoSmithKline Pharmaceuticals announces results for fifteen months period ending March 31, 2015
Sale of products (net of excise duty) increased by 29 per cent during the same period GlaxoSmithKline Pharmaceuticals announced…
GlaxoSmithKline Pharmaceuticals announces Q4 results
Net sales of the pharmaceuticals business grew by 1.2 per cent during the quarter ended December 31, 2014